Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Daktronics' Q2 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Fall
Daktronics' Q2 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Fall

Daktronics DAKT shares fell 1.87% to close at $20.51 on Thursday following second-quarter fiscal 2026 results reported on Dec. 10. Earnings of 35 cents per share surpassed the Zacks Consensus

Kymera's Eczema Drug Gets Fast Track Designation in the United States
Kymera's Eczema Drug Gets Fast Track Designation in the United States

Kymera Therapeutics, Inc. KYMR recently announced that the FDA granted Fast Track designation to pipeline candidate KT-621 for the treatment of moderate to severe atopic dermatitis (AD), the most

ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA Platform
ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA Platform

AtriCure ATRC recently took a major step forward in surgical ablation innovation with the first patients successfully treated using its new dual-energy platform. The system uniquely pairs Pulsed

Can Verizon's Empower Field Network Infrastructure Upgrade Aid Shares?
Can Verizon's Empower Field Network Infrastructure Upgrade Aid Shares?

Verizon Communications Inc. (VZ) has introduced a new Wi-Fi 6E network at Empower Field at Mile High, home of the Denver Broncos. With Verizon’s upgraded Wi-Fi 6E and LAN, fans can now enjoy a

Clorox's Brand Investments Are Up: Will They Translate to Growth?
Clorox's Brand Investments Are Up: Will They Translate to Growth?

The Clorox Company’s CLX brand investments are increasing due to heightened demand creation strategies, including higher trade spending and advertising to support innovations planned for the second

DraftKings' iGaming Up 25%: A Second Growth Engine Emerging?
DraftKings' iGaming Up 25%: A Second Growth Engine Emerging?

DraftKings Inc. DKNG delivered one of its strongest iGaming performances in recent years, with third-quarter net revenues climbing 25% year over year, marking the fastest pace since early 2024. This

Is Comfort Systems Positioned for Long-Term Pharma Project Demand?Photo, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
Is Comfort Systems Positioned for Long-Term Pharma Project Demand?

Comfort Systems USA, Inc. FIX is seeing rising activity across sectors that depend on complex mechanical and electrical systems and one area showing growing visibility is pharma and life sciences

Can Flex Offset Automotive Headwinds in Its Reliability Segment?Photo, wide shot, wide-angle lens,  Automotive service center, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/c8dbaa5e-abdb-40ac-b919-ed80785b056a.png
Can Flex Offset Automotive Headwinds in Its Reliability Segment?

Flex Ltd. FLEX is witnessing strong business performance, largely driven by surging demand across its data center and high-value, technology-driven businesses. Even as momentum builds across other

Can PLAY's Revamped Remodel Blueprint Catalyze Its Next Growth Cycle?
Can PLAY's Revamped Remodel Blueprint Catalyze Its Next Growth Cycle?

Dave & Buster's Entertainment, Inc. PLAY is advancing a more focused and efficiency-oriented remodel strategy that management highlighted as a key component of its Back to Basics plan. In the third

Suncor Unveils 2026 Guidance Focused on Growth & Superior Returns
Suncor Unveils 2026 Guidance Focused on Growth & Superior Returns

Suncor Energy Inc. SU has released its 2026 corporate guidance, reinforcing its commitment to operational excellence, disciplined capital allocation and sustained shareholder value creation

GSK Gets FDA Nod for Blujepa in Uncomplicated Urogenital Gonorrhea
GSK Gets FDA Nod for Blujepa in Uncomplicated Urogenital Gonorrhea

GSK plc GSK announced that the FDA has approved its supplemental new drug application (sNDA) seeking approval for its oral antibiotic Blujepa (gepotidacin) for treating uncomplicated urogenital

Here's Why 2026 Could Be a Breakout Year for India ETFs
Here's Why 2026 Could Be a Breakout Year for India ETFs

India’s markets started December with a stumble, with the NIFTY 50 falling about 0.47% month to date. However, the sentiment appears to be shifting. The index, representing 50 of the largest

Will the CEC Acquisition Strengthen Sterling's Margin Profile in 2026?
Will the CEC Acquisition Strengthen Sterling's Margin Profile in 2026?

Sterling Infrastructure, Inc. STRL is taking a meaningful step forward with the acquisition of CEC, expanding capabilities across mission-critical end markets and strengthening its position for

Can MRK's New Drugs & Pipeline Help Navigate the Looming Keytruda LOE?
Can MRK's New Drugs & Pipeline Help Navigate the Looming Keytruda LOE?

Merck MRK is focusing on driving its long-term growth with its new products and a promising set of pipeline candidates as its blockbuster PD-L1 inhibitor, Keytruda, faces patent expiration in 2028.

CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution
CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution

CeriBell Inc. CBLL recently announced that the FDA has given 510(k) clearance for its latest delirium monitoring solution, making it the one and only FDA-cleared solution for continuous tracking of

Fed Cuts Rate: Will This Accelerate Morgan Stanley's IB Fee Growth?Photo, wide shot, wide-angle lens,  Bank, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/094456a7-d529-4ef2-b536-c031f2afd618.png
Fed Cuts Rate: Will This Accelerate Morgan Stanley's IB Fee Growth?

The Federal Reserve has implemented its third consecutive 25-basis-point rate cut this year, reigniting investor optimism. The move is expected to support the ongoing strong resurgence in

Carnival (CCL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Carnival (CCL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The market expects Carnival (CCL) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended November 2025. This widely-known consensus

Conagra Brands (CAG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Conagra Brands (CAG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

The market expects Conagra Brands (CAG) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended November 2025. This widely-known consensus

Best Momentum Stock to Buy for December 12th
Best Momentum Stock to Buy for December 12th

Here is the stock with buy rank and strong momentum characteristics for investors to consider today, December 12th:

Kohl's KSS: This U.S. based department store chain, that operates specialty stores

Can DUK's Massive Clean Energy Investments Drive Long-Term Growth?Photo, wide shot, wide-angle lens,  Gas company, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/07ff6859-914a-4fdd-8473-abdbac8978f6.png
Can DUK's Massive Clean Energy Investments Drive Long-Term Growth?

Duke Energy DUK is investing heavily in renewable energy and modernizing its power grid, which strengthens its ability to meet long-term decarbonization goals while supporting new electricity

TJX Stock Up 30% in 2025: What's the Smart Move for 2026?
TJX Stock Up 30% in 2025: What's the Smart Move for 2026?

The TJX Companies, Inc. (TJX) has been a clear standout performer in 2025, with shares surging 30.4% year to date. This strong rally reflects investor confidence in TJX’s off-price model, consistent

After a 42% Six-Month Rally, What's Next for Apple Stock in 2026?
After a 42% Six-Month Rally, What's Next for Apple Stock in 2026?

Apple AAPL shares have appreciated 41.5% over the trailing six-month period, outperforming the Zacks Computer and Technology sector’s return of 28.4%. The outperformance can be attributed to

Does Life Time Group Holdings (LTH) Have the Potential to Rally 54.09% as Wall Street Analysts Expect?
Does Life Time Group Holdings (LTH) Have the Potential to Rally 54.09% as Wall Street Analysts Expect?

Shares of Life Time Group Holdings, Inc. (LTH) have gained 1.7% over the past four weeks to close the last trading session at $25.9, but there could still be a solid upside left in the stock if

Does Marvell (MRVL) Have the Potential to Rally 28.26% as Wall Street Analysts Expect?
Does Marvell (MRVL) Have the Potential to Rally 28.26% as Wall Street Analysts Expect?

Marvell Technology (MRVL) closed the last trading session at $89.43, gaining 2.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

How Much Upside is Left in Loar Holdings Inc. (LOAR)? Wall Street Analysts Think 29.61%
How Much Upside is Left in Loar Holdings Inc. (LOAR)? Wall Street Analysts Think 29.61%

Loar Holdings Inc. (LOAR) closed the last trading session at $71.37, gaining 4.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by